GRM5 and Cognitive impairment: We also showed a primate gained TAD boundary containing the gene GRM5, a promising target for the treatment of cognitive deficits in schizophrenia [45], which may be involved in the regulation of neural network activity and synaptic plasticity [46] (Additional file 2: Fig. S9B).